NEW YORK (Reuters) -Johnson & Johnson on Wednesday priced the initial public offering (IPO) of its consumer-health business at the upper end of its target range to raise $3.66 billion, a person familiar with the matter said. Kenvue Inc defied volatile market conditions to price about 166 million shares at…Read More
JJs Kenvue prices IPO within range to raise 37 billion source
